MedPath

Study to Evaluate the Efficacy of Bare Performance Nutrition's Peak Sleep Supplementation on Sleep Quality and Duration.

Not Applicable
Completed
Conditions
Sleep
Registration Number
NCT05222919
Lead Sponsor
Bare Performance Nutrition
Brief Summary

This is a single-blinded observational randomized-control trial to study the efficacy of a dietary supplement and its effect on sleep quality, recovery, and workout performance.

Detailed Description

This is a single-blinded observational randomized-control trial to study the efficacy of a dietary supplement and its effect on sleep quality, recovery, and workout performance.

It is hypothesized that the dietary supplement "Peak Sleep" will improve sleep quality - as defined as deep sleep, REM sleep, and feeling more rested the next day, as well as promoting the performance in workouts of trial participants.

A total of 72 participants will be recruited for the trial following the screening. The trial will be fully remote, a technology platform will be utilized to screen, enroll and capture study data of the participants, and participants will either receive the "Peak Sleep" product or receive a placebo - depending on the study group they got randomized in - for eight weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
72
Inclusion Criteria
  • Male & Female between 24-45 years old
  • Self-reported mild to moderate sleep issues
  • 3+ days of physical exercise per week
  • Self-reported stressful lifestyle
  • Own a sleep tracker that can be used for the study (e.g. Oura ring, Apple Watch, FitBit, -Whoop band, or similar other devices)
  • Must be in good health (don't report any medical conditions asked in the screening questionnaire)
  • Following a stable, consistent diet regimen
  • Willing to maintain current dietary pattern, activity level, and stable body weight for the duration of the study, and refrain from any drastic lifestyle changes
Exclusion Criteria
  • Severe chronic conditions including oncological conditions, psychiatric disease, or other
  • Diagnosed insomnia
  • Food intolerances/allergies that require an EpiPen
  • Females that are pregnant, want to become pregnant for the duration of the study, or who are breastfeeding
  • Individuals that participate in another research study during the study period
  • Individuals with a history of drug, alcohol, or substance abuse
  • Individuals taking any other sleep supplements and are unwilling to stop taking those supplements for the duration of the study period
  • Individuals who have night terrors regularly
  • Individuals who regularly sleepwalk
  • Individuals who have regular bad dreams

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in sleep qualityBaseline to 8 weeks

Survey-based assessment (0-5 scale with 0 being the lowest possible score and 5 being the highest) of changes in sleep quality between baseline and study intervention period.

Change in recovery time after a workoutBaseline to 8 weeks

Survey-based assessment (0-5 scale with 0 being the lowest possible score and 5 being the highest) of changes in workout recovery time between baseline and study intervention period.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Citruslabs

🇺🇸

Santa Monica, California, United States

Citruslabs
🇺🇸Santa Monica, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.